Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is one of the best hot stocks to buy according to Wall Street analysts.

Gallant’s first stem cell therapy kit is aimed at tackling a painful mouth condition in cats and is on track for US FDA ...

Stereotaxis' high-margin catheters and instruments convert its lumpier equipment business into a software-like medtech story.

Roivant Sciences' 44% return highlights potential in its pipeline and partnerships. I maintain a cautious stance on RIOV ...

The FDA’s decision to clear the Apple Watch is a big deal because it shows they are open to new kinds of medical devices. It ...

The bills passed 61-44 on July 1 and would allow police to collect saliva to detect THC, cocaine and other drugs, replacing ...

The Trump administration on Thursday recalled its top diplomat in Colombia for “urgent consultations” after recent comments ...

Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Ozempic could help with his as a study by Goldman Sachs found that the mass-adoption of GLP-1 series drugs could allow for ...

The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two COVID-19 vaccines, disregarding recommendations from government scientists.

NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Dizal's oral EGFR inhibitor Zegfrovy (sunvozertinib) as a treatment for patients with locally advanced or ...